TriSalus Life Sciences Inc
TLSI
Get informed when a big investor buys or sells
+ FollowMarket Cap$287.25M
Close$
$-8.19
267.2% downside
Current Fair Value
267.2% downsideOvervalued by 267.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $287.25 Million |
|---|---|
| Enterprise Value | $275.38 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.84 |
| Beta | 0.44 |
| Outstanding Shares | 58,296,711 |
Return
| Return on Equity | -895.80% |
|---|---|
| Return on Assets | -93.96% |
| Return on Invested Capital | -55.68% |
Valuation & Multiples
| P/E Ratio | -3.59 |
|---|---|
| PEG | -33.08 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 6.11 |
| Enterprise Value to EBIT | -9.64 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 5.26 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.15
Average shareholder expectationRevenue Estimate
$10.27 M
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.12
Average shareholder expectationRevenue Estimate
$14.31 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 37.52%▼ 2.95% |
|---|---|
| Total Invested | $99.51M▲ 19.29% |
| Investors Holding | 81▼ 4.00% |
ESG Score
No data